RVL Pharmaceuticals plc
RVLPDelisted Nov 20, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001739426
RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in RVL Pharmaceuticals plc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −10 vs. Q3 2022
- Shares held
- 25.1M
- +1.08M (+4.5%) vs. Q3 2022
- Total value
- $28.0M
- −$22.5M (−44.5%) vs. Q3 2022
- New holders
- 1
- 13 more added
- Sold out
- 11
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVLP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $613 |
| Q3 2023 | 32 | $1.57M |
| Q2 2023 | 36 | $13.5M |
| Q1 2023 | 41 | $28.7M |
| Q4 2022 | 36 | $28.0M |
| Q3 2022 | 46 | $50.5M |
| Q2 2022 | 38 | $22.2M |
| Q1 2022 | 36 | $27.8M |
| Q4 2021 | 31 | $18.7M |
| Q3 2021 | 35 | $11.9M |
| Q2 2021 | 46 | $14.5M |
| Q1 2021 | 55 | $25.7M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding RVL Pharmaceuticals plc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 3 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 7 | $8 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,187 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,382 | $1.55K | 0.00% | −10,012−87.9% | Reduced |
| Bank of America Corp | 1,720 | $1.93K | 0.00% | 00.0% | Unchanged |
| Tower View Investment Management & Research LLC | 4,100 | $5.00K | 0.00% | 00.0% | Unchanged |
| SFMG, LLC | 10,000 | $11.2K | 0.00% | 00.0% | Unchanged |
| Williams Jones Wealth Management, LLC. | 10,000 | $11.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,078 | $13.5K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,322 | $14.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 14,100 | $15.8K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 16,723 | $18.7K | 0.00% | −6,994−29.5% | Reduced |
| Atria Wealth Solutions, Inc. | 23,000 | $25.8K | 0.00% | −4,000−14.8% | Reduced |
| Barclays PLC | 23,317 | $26.1K | 0.00% | +20,468+718.4% | Added |
| Raymond James Financial Services Advisors, Inc. | 29,519 | $33.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 31,500 | $35.3K | 0.00% | +31,500 | New |
| Insight Advisors, LLC | 37,823 | $43.5K | 0.02% | 00.0% | Unchanged |
| Virtu Financial LLC | 39,818 | $45.0K | 0.01% | +16,983+74.4% | Added |
| Citadel Advisors LLC | 47,143 | $52.8K | 0.00% | +25,582+118.6% | Added |
| Northern Trust Corp | 72,899 | $81.6K | 0.00% | +8,427+13.1% | Added |
| State Street Corp | 78,687 | $88.1K | 0.00% | +6,500+9.0% | Added |
| Titleist Asset Management, Ltd. | 92,503 | $103.6K | 0.02% | −5,648−5.8% | Reduced |
| Dimensional Fund Advisors LP | 96,151 | $108.0K | 0.00% | +9,790+11.3% | Added |
| Marietta Wealth Management, LLC | 120,000 | $134.4K | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 120,906 | $135.4K | 0.00% | +106,243+724.6% | Added |
| Millennium Management LLC | 173,947 | $195.0K | 0.00% | +11,719+7.2% | Added |
| BlackRock Inc. | 202,642 | $227.0K | 0.00% | +1,223+0.6% | Added |
| Vanguard Group Inc | 246,353 | $275.9K | 0.00% | +23,918+10.8% | Added |
| Geode Capital Management, LLC | 307,266 | $344.0K | 0.00% | +2,884+0.9% | Added |
| Worth Venture Partners, LLC | 455,960 | $510.7K | 0.30% | +270,313+145.6% | Added |
| Renaissance Technologies LLC | 715,215 | $801.0K | 0.00% | −56,792−7.4% | Reduced |
| Morgan Stanley | 1,096,633 | $1.23M | 0.00% | −76,571−6.5% | Reduced |
| ArrowMark Colorado Holdings LLC | 1,623,000 | $1.82M | 0.02% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 1,801,864 | $2.02M | 0.67% | +1,062,333+143.6% | Added |
| Rovida Advisors Inc. | 3,000,000 | $3.24M | 1.19% | 00.0% | Unchanged |
| Athyrium Capital Management, LP | 14,600,444 | $16.4M | 6.87% | 00.0% | Unchanged |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −276,428−100.0% | Sold out |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,298−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,483−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −10,927−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −8,356−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −1,650−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −306−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| Tilia Fiduciary Partners, Inc. | 0 | $0 | 0.00% | −435−100.0% | Sold out |